Meanwhile, in the US, the wobbling new issues market saw Medco, a spin-off from pharmaceuticals giant Merck, delay its debut until next week. Under pressure from its banks to repay loans, embattled Tyco International, however, is still set to go to market next week with one of the largest spin-offs this year.